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Background
Atrial (ANP), B-type (BNP) and C-type (CNP) natriure-
tic peptide levels are increased in heart failure. Natriure-
tic peptides mediate their effects through natriuretic
peptide receptors (NPRs), ANP and BNP preferentially
through NPR-A and CNP through NPR-B. NPRs are
membrane bound guanylyl cyclases that increase cyclic
GMP (cGMP) production when activated. Increased
cGMP levels may have beneficial cardiovascular effects
through protein kinase G. In contrast, we have pre-
viously shown that NPR-B stimulation by CNP enhances
b1-adrenoceptor (b1-AR) mediated signaling in failing
hearts through inhibition of phosphodiesterase 3 (PDE3)
[1]. This cardioexcitatory influence is longstanding and
is thus probably detrimental in the failing heart. How-
ever, a comparison of the PDE3 inhibitory effect of
NPR-B signaling in non-failing and failing hearts was
not elucidated.
Methods
Heart failure was induced in male Wistar rats by coron-
ary artery ligation. Contraction studies were performed
ex vivo in left ventricular muscle strips in the presence
of appropriate receptor antagonists.
Results and conclusion
We now demonstrate that CNP through NPR-B is able
to potently inhibit PDE3 and thus increase cAMP sig-
naling in non-failing as in failing hearts. This was evi-
dent from a marked ability of CNP to potentiate the
inotropic and lusitropic responses to b1-AR stimulation
in left ventricular strips. This conserved mechanism may
enhance detrimental b1-AR effects during pathological
remodeling, and may contribute to the development of
the failing cardiac phenotype.
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